Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

Lignende værker

• Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies
  af: Twelves, Chris, et al.
  Udgivet: (2014)
• Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer
  af: Twelves, Chris, et al.
  Udgivet: (2016)
• Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
  af: Kaufman, Peter A., et al.
  Udgivet: (2015)
• Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: A post hoc pooled analysis
  af: Cortes, Javier, et al.
  Udgivet: (2019)
• Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial
  af: Cortes, Javier, et al.
  Udgivet: (2015)